LEADER 02169oam 2200625 450 001 9910714201603321 005 20190225132349.0 035 $a(CKB)3790000000050125 035 $a(OCoLC)681839503$z(OCoLC)622659724$z(OCoLC)655155094$z(OCoLC)1011888248$z(OCoLC)1022042518$z(OCoLC)1067251591 035 $a(EXLCZ)993790000000050125 100 $a20101117d2000 ua 0 101 0 $aeng 135 $aurbn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aHow accurate is the FDA's monitoring of supplements like ephedra? $ehearing before the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, first session, May 27, 1999 210 1$aWashington :$cU.S. Government Printing Office,$d2000. 215 $a1 online resource (iii, 214 pages) $cillustrations 300 $a"Serial no. 106-60." 320 $aIncludes bibliographical references. 517 $aHow accurate is the FDA's monitoring of supplements like ephedra? 606 $aDietary supplements$xGovernment policy$zUnited States 606 $aDrugs$xSide effects$xGovernment policy$zUnited States 606 $aProduct safety$zUnited States 606 $aEphedra$xTherapeutic use$xSide effects$zUnited States 606 $aDietary supplements$2fast 607 $aUnited States$2fast 608 $aRules.$2fast 608 $aLegislative hearings.$2lcgft 615 0$aDietary supplements$xGovernment policy 615 0$aDrugs$xSide effects$xGovernment policy 615 0$aProduct safety 615 0$aEphedra$xTherapeutic use$xSide effects 615 7$aDietary supplements. 676 $a353.9/97/0973 801 0$bOCLCE 801 1$bOCLCE 801 2$bOCLCQ 801 2$bOCLCF 801 2$bOCLCO 801 2$bOCLCA 801 2$bOCLCQ 801 2$bCWCLL 801 2$bNJR 801 2$bOCLCQ 801 2$bOCL 801 2$bOCLCA 801 2$bUWO 801 2$bOCLCQ 801 2$bGPO 906 $aBOOK 912 $a9910714201603321 996 $aHow accurate is the FDA's monitoring of supplements like ephedra$93466097 997 $aUNINA